Bristol Myers Squibb · 2 weeks ago
Associate Director, FP&A Portfolio Analysis
Princeton, NJ
Full-time
Onsite
Lead/Staff, Director/Executive
$162K/yr - $196K/yrBristol Myers Squibb is a company dedicated to transforming patients' lives through science. The Associate Director, FP&A Portfolio Analysis will lead the development of annual budgets and forecasts for R&D Portfolio spend, ensuring alignment with strategic priorities and collaborating closely with various teams to support financial planning and decision-making.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Lead the development of annual budgets, quarterly forecasts, and long-range financial plans for R&D Portfolio spend (grants, supplies and alliances), ensuring alignment with strategic priorities
Own month-end and Qtr. close narratives and variance analysis; synthesize insights into concise materials for senior leadership reviews, consolidating financials across therapeutic areas in close collaboration with the Hyderabad FP&A Hub team
Deliver timely and insightful reporting to R&D leadership and assist in preparing presentations to senior leaders and business partners
Govern high quality submissions across planning systems (Anaplan; Hyperion), ensuring data integrity, controls, and on-time deliverables
Track and analyze actuals vs. plan, identify drivers of variance and provide insights on financial health of the R&D Portfolio, analyze and identify drivers of spending trends and forecasts
Collaborate closely with Therapeutic Area Finance Leads, R&D Portfolio Finance, Portfolio Strategy and Operations, BI&T and the Hyderabad FP&A hub team to ensure cohesive financial planning and support decision-making
Champion process simplification, standardization, and automation across the planning and reporting cycle, working in concert with the Hub team
Enhance digital solutions (self-service dashboards, data visualization, modeling accelerators) that reduce cycle time and raise decision quality
Drive simplification and automation of reporting processes, leveraging tools such as SAP, Hyperion, Excel, and Power BI
Ensure compliance with internal controls, accounting standards, and corporate policies
Effectively partner with the R&D Portfolio FP&A team to ensure standardized guidelines are communicated and followed across the portfolio
Ensure relevant accounting procedures and controls are in place and operating, and all requirements for US GAAP are fulfilled
Qualification
Required
Lead the development of annual budgets, quarterly forecasts, and long-range financial plans for R&D Portfolio spend (grants, supplies and alliances), ensuring alignment with strategic priorities
Own month-end and Qtr. close narratives and variance analysis; synthesize insights into concise materials for senior leadership reviews, consolidating financials across therapeutic areas in close collaboration with the Hyderabad FP&A Hub team
Deliver timely and insightful reporting to R&D leadership and assist in preparing presentations to senior leaders and business partners
Govern high quality submissions across planning systems (Anaplan; Hyperion), ensuring data integrity, controls, and on-time deliverables
Track and analyze actuals vs. plan, identify drivers of variance and provide insights on financial health of the R&D Portfolio
Analyze and identify drivers of spending trends and forecasts
Collaborate closely with Therapeutic Area Finance Leads, R&D Portfolio Finance, Portfolio Strategy and Operations, BI&T and the Hyderabad FP&A hub team to ensure cohesive financial planning and support decision-making
Champion process simplification, standardization, and automation across the planning and reporting cycle, working in concert with the Hub team
Enhance digital solutions (self-service dashboards, data visualization, modeling accelerators) that reduce cycle time and raise decision quality
Drive simplification and automation of reporting processes, leveraging tools such as SAP, Hyperion, Excel, and Power BI
Ensure compliance with internal controls, accounting standards, and corporate policies
Effectively partner with the R&D Portfolio FP&A team to ensure standardized guidelines are communicated and followed across the portfolio
Ensure relevant accounting procedures and controls are in place and operating, and all requirements for US GAAP are fulfilled
Benefits
Health Coverage: Medical, pharmacy, dental, and vision care.
Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
Financial Well-being and Protection: 401(k) plan, short- and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
Paid Time Off
US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees)
Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays
Additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.
Company
Bristol Myers Squibb
At Bristol Myers Squibb, we work every day to transform patients’ lives through science.
Founded in 1887
10001+ employees
H1B Sponsorship
Bristol Myers Squibb has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (247)
2024 (278)
2023 (231)
2022 (180)
2021 (181)
2020 (169)
Funding
Current Stage
Public CompanyTotal Funding
$29.32BKey Investors
Venrock
2025-11-05Post Ipo Debt· $5.74B
2024-02-14Post Ipo Debt· $13B
2023-10-30Post Ipo Debt· $4.5B
Leadership Team
Charles Bancroft
CFO
Cristian Massacesi
Executive Vice President, Chief Medical Officer and Head of Development
Recent News
Company data provided by crunchbase